SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-114435
Filing Date
2022-11-03
Accepted
2022-11-03 16:30:47
Documents
20
Period of Report
2022-11-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229551d1_8k.htm   iXBRL 8-K 32830
2 EXHIBIT 4.1 tm2229551d1_ex4-1.htm EX-4.1 90868
3 EXHIBIT 4.2 tm2229551d1_ex4-2.htm EX-4.2 90695
4 EXHIBIT 10.1 tm2229551d1_ex10-1.htm EX-10.1 235162
5 EXHIBIT 10.2 tm2229551d1_ex10-2.htm EX-10.2 179939
6 EXHIBIT 99.1 tm2229551d1_ex99-1.htm EX-99.1 10082
10 GRAPHIC tm2229551d1_ex10-1img01.jpg GRAPHIC 8474
11 GRAPHIC tm2229551d1_ex10-2img01.jpg GRAPHIC 8474
12 GRAPHIC image_001.jpg GRAPHIC 7657
  Complete submission text file 0001104659-22-114435.txt   969763

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA edsa-20221102.xsd EX-101.SCH 3045
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20221102_lab.xml EX-101.LAB 34476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20221102_pre.xml EX-101.PRE 22603
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2229551d1_8k_htm.xml XML 3572
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 221358532
SIC: 2834 Pharmaceutical Preparations